Muscle and fat composition in patients with newly diagnosed multiple myeloma - Summary - MDSpire

Muscle and fat composition in patients with newly diagnosed multiple myeloma

  • By

  • Nadine H. Abdallah

  • Hiroki Nagayama

  • Naoki Takahashi

  • Wilson Gonsalves

  • Amie Fonder

  • Angela Dispenzieri

  • David Dingli

  • Francis K. Buadi

  • Martha Q. Lacy

  • Miriam Hobbs

  • Morie A. Gertz

  • Moritz Binder

  • Prashant Kapoor

  • Rahma Warsame

  • Suzanne R. Hayman

  • Taxiarchis Kourelis

  • Yi L. Hwa

  • Yi Lin

  • Robert A. Kyle

  • S. Vincent Rajkumar

  • Stephen M. Broski

  • Shaji K. Kumar

  • December 12, 2023

  • 0 min

Share

Objective:

To evaluate the prognostic impact of muscle and fat content and quality assessed by 18F-FDG PET/CT in newly diagnosed patients with multiple myeloma, highlighting its significance in improving patient outcomes.

Key Findings:
  • Sarcopenia and fat composition metrics showed variability in prognostic impact across the patient population, indicating the need for tailored approaches in treatment.
Interpretation:

The study highlights the need for further investigation into the role of body composition in the prognosis of multiple myeloma, given the variability in outcomes associated with muscle and fat metrics, which could inform clinical decision-making.

Limitations:
  • 123
Conclusion:

Body composition analysis using 18F-FDG PET/CT may provide valuable prognostic information in newly diagnosed multiple myeloma patients, warranting further research to explore its clinical applications.

Original Source(s)

Related Content